Integrin-Linked Kinase Plays An Active Role In The Regulation Of Endothelial Senescence

Aging Pathway
Therapeutic
Integrin-Linked Kinase (ILK) is a key regulator of endothelial cell function and aging, with its reduced levels contributing to cellular dysfunction and its restoration improving cell health.
Author

Gemini

Published

June 25, 2026

Our blood vessels are lined by special cells called endothelial cells, which are vital for maintaining healthy circulation and preventing diseases like heart conditions. As we age, these cells can enter a state called senescence, where they stop dividing and start to malfunction, contributing to age-related vascular problems. Recent research has shed light on a crucial protein involved in this process.

This protein, known as Integrin-Linked Kinase (ILK), acts as a vital link between the outside of the cell and its internal machinery. It helps endothelial cells sense their environment and transmit signals, playing a role in their proper functioning. The study found that in aging endothelial cells, the levels of ILK are significantly reduced.

To understand ILK’s role better, scientists conducted experiments where they reduced ILK in young, healthy endothelial cells. This led to the cells prematurely exhibiting characteristics of senescence and showing signs of dysfunction. Conversely, when ILK levels were restored in senescent cells, their function improved, and markers of aging were reduced.

These findings suggest that ILK is not just correlated with the aging of blood vessel lining cells, but actively regulates their function and senescence. This makes ILK a promising target for developing new treatments aimed at combating age-related decline in our blood vessels and improving cardiovascular health.


Source: link to paper